Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (FY)Dec 31, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 902.09M | 7.17%3.47B | 10.69%869.28M | 8.72%871.41M | 6.18%3.24B | 857.4M | 1.10%796.35M | 8.40%785.31M | 8.96%801.48M | 13.46%3.05B |
| Cost of revenue | 266.49M | 4.25%1.03B | 12.25%266.63M | 2.96%249.19M | 1.49%987.46M | 261.19M | -6.63%246.72M | 8.64%237.53M | 7.29%242.02M | 21.10%973M |
| Gross profit | 635.6M | 8.45%2.44B | 10.02%602.65M | 11.22%622.22M | 8.38%2.25B | 596.22M | 5.00%549.63M | 8.30%547.77M | 9.70%559.46M | 10.21%2.08B |
| Operating expense | 512.61M | 15.92%1.89B | 3.06%438.43M | 17.01%401.19M | 8.58%1.63B | 436.85M | 8.49%422.57M | 11.86%425.41M | 0.54%342.87M | 7.23%1.5B |
| Operating profit | 122.99M | -10.99%556.63M | 34.21%164.23M | 2.05%221.03M | 7.85%625.37M | 159.36M | -5.16%127.06M | -2.50%122.37M | 28.19%216.59M | 18.73%579.86M |
| Net non-operating interest income (expenses) | -72K | -6,265.22%-1.46M | 256.25%25K | 200.00%21K | 88.08%-23K | 13K | 102.44%1K | 71.93%-16K | 64.41%-21K | 43.57%-193K |
| Non-operating interest income | --908K | 105.50%224K | 80.00%36K | 80.95%38K | 159.52%109K | --36K | 113.33%32K | 300.00%20K | 162.50%21K | 90.91%42K |
| Non-operating interest expense | --980K | 1,178.79%1.69M | -69.44%11K | -59.52%17K | -43.83%132K | --23K | -44.64%31K | -41.94%36K | -37.31%42K | -35.44%235K |
| Net investment income | 2.33M | 467.49%7.09M | -4.46%-2.41M | 95.60%1.73M | 110.58%1.25M | 2.82M | 87.33%-148K | 75.34%-2.31M | 125.01%886K | -95.34%-11.81M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 3.24M | 0 | 15.81M | ||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | 41.28M | 163.65%50.38M | 1,620.34%5.08M | 11,516.67%697K | 561.47%19.11M | -848K | 323.92%19.66M | 793.94%295K | 107.79%6K | -53.72%2.89M |
| Income before tax | 172.21M | -4.62%615.87M | 41.40%170.15M | 2.77%223.48M | 10.09%645.71M | 161.35M | 6.67%146.57M | 3.64%120.34M | 31.57%217.46M | 22.15%586.55M |
| Income tax | 58.42M | -26.30%137.14M | 30.28%56.86M | -40.12%43.17M | 4.29%186.08M | 18.57M | 14.14%51.77M | 12.97%43.65M | 52.42%72.09M | 24.04%178.43M |
| Net income | 113.8M | 4.16%478.73M | 47.72%113.29M | 24.04%180.31M | 12.62%459.63M | 142.78M | 2.99%94.8M | -1.01%76.69M | 23.21%145.36M | 21.34%408.12M |
| Net income continuous operations | --113.79M | 4.16%478.73M | 47.72%113.29M | 24.04%180.31M | 12.62%459.63M | --142.78M | 2.99%94.79M | -1.01%76.69M | 23.21%145.36M | 21.34%408.12M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 113.8M | 4.16%478.73M | 47.72%113.29M | 24.04%180.31M | 12.62%459.63M | 142.78M | 2.99%94.8M | -1.01%76.69M | 23.21%145.36M | 21.34%408.12M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 113.8M | 4.16%478.73M | 47.72%113.29M | 24.04%180.31M | 12.62%459.63M | 142.78M | 2.99%94.8M | -1.01%76.69M | 23.21%145.36M | 21.34%408.12M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 17.29 | 3.96%72.11 | 47.32%17.03 | 24.07%27.22 | 12.65%69.36 | 21.57 | 2.95%14.29 | -1.03%11.56 | 23.19%21.94 | 20.96%61.57 |
| Diluted earnings per share | 17.26 | 4.60%71.89 | 48.56%17.01 | 24.70%27.11 | 13.17%68.73 | 21.37 | 3.51%14.17 | -0.52%11.45 | 23.87%21.74 | 21.46%60.73 |
| Dividend per share | ||||||||||
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |